120 related articles for article (PubMed ID: 27840051)
1. Ro 90-7501 inhibits PP5 through a novel, TPR-dependent mechanism.
Hong TJ; Park K; Choi EW; Hahn JS
Biochem Biophys Res Commun; 2017 Jan; 482(2):215-220. PubMed ID: 27840051
[TBL] [Abstract][Full Text] [Related]
2. Selective activators of protein phosphatase 5 target the auto-inhibitory mechanism.
Haslbeck V; Drazic A; Eckl JM; Alte F; Helmuth M; Popowicz G; Schmidt W; Braun F; Weiwad M; Fischer G; Gemmecker G; Sattler M; Striggow F; Groll M; Richter K
Biosci Rep; 2015 Apr; 35(3):. PubMed ID: 26182372
[TBL] [Abstract][Full Text] [Related]
3. Interactions of cantharidin-like inhibitors with human protein phosphatase-5 in a Mg
Assis LC; de Castro AA; Prandi IG; Mancini DT; de Giacoppo JOS; Savedra RML; de Assis TM; Carregal JB; da Cunha EFF; Ramalho TC
J Mol Model; 2018 Oct; 24(10):303. PubMed ID: 30280322
[TBL] [Abstract][Full Text] [Related]
4. Rac GTPase signaling through the PP5 protein phosphatase.
Gentile S; Darden T; Erxleben C; Romeo C; Russo A; Martin N; Rossie S; Armstrong DL
Proc Natl Acad Sci U S A; 2006 Mar; 103(13):5202-6. PubMed ID: 16549782
[TBL] [Abstract][Full Text] [Related]
5. Identification of amino acids in the tetratricopeptide repeat and C-terminal domains of protein phosphatase 5 involved in autoinhibition and lipid activation.
Kang H; Sayner SL; Gross KL; Russell LC; Chinkers M
Biochemistry; 2001 Sep; 40(35):10485-90. PubMed ID: 11523989
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a robust and sensitive assay for the discovery of selective inhibitors for serine/threonine protein phosphatases PP1α (PPP1C) and PP5 (PPP5C).
Swingle MR; Honkanen RE
Assay Drug Dev Technol; 2014 Oct; 12(8):481-96. PubMed ID: 25383722
[TBL] [Abstract][Full Text] [Related]
7. A novel tetratricopeptide repeat (TPR) containing PP5 serine/threonine protein phosphatase in the malaria parasite, Plasmodium falciparum.
Dobson S; Kar B; Kumar R; Adams B; Barik S
BMC Microbiol; 2001; 1():31. PubMed ID: 11737864
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures and mutagenesis of PPP-family ser/thr protein phosphatases elucidate the selectivity of cantharidin and novel norcantharidin-based inhibitors of PP5C.
Chattopadhyay D; Swingle MR; Salter EA; Wood E; D'Arcy B; Zivanov C; Abney K; Musiyenko A; Rusin SF; Kettenbach A; Yet L; Schroeder CE; Golden JE; Dunham WH; Gingras AC; Banerjee S; Forbes D; Wierzbicki A; Honkanen RE
Biochem Pharmacol; 2016 Jun; 109():14-26. PubMed ID: 27002182
[TBL] [Abstract][Full Text] [Related]
9. Structure and function of the co-chaperone protein phosphatase 5 in cancer.
Sager RA; Dushukyan N; Woodford M; Mollapour M
Cell Stress Chaperones; 2020 May; 25(3):383-394. PubMed ID: 32239474
[TBL] [Abstract][Full Text] [Related]
10. Characterization of protein phosphatase 5 from three lepidopteran insects: Helicoverpa armigera, Mythimna separata and Plutella xylostella.
Chen X; Lü S; Zhang Y
PLoS One; 2014; 9(5):e97437. PubMed ID: 24823652
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional basis of protein phosphatase 5 substrate specificity.
Oberoi J; Dunn DM; Woodford MR; Mariotti L; Schulman J; Bourboulia D; Mollapour M; Vaughan CK
Proc Natl Acad Sci U S A; 2016 Aug; 113(32):9009-14. PubMed ID: 27466404
[TBL] [Abstract][Full Text] [Related]
12. Insights into the key interactions between human protein phosphatase 5 and cantharidin using molecular dynamics and site-directed mutagenesis bioassays.
Liu JY; Chen XE; Zhang YL
Sci Rep; 2015 Jul; 5():12359. PubMed ID: 26190207
[TBL] [Abstract][Full Text] [Related]
13. Suramin is a novel activator of PP5 and biphasically modulates S100-activated PP5 activity.
Yamaguchi F; Yamamura S; Shimamoto S; Tokumitsu H; Tokuda M; Kobayashi R
Appl Biochem Biotechnol; 2014 Jan; 172(1):237-47. PubMed ID: 24068474
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the tetratricopeptide-containing domain of BUB1, BUBR1, and PP5 proves that domain amphiphilicity over amino acid sequence specificity governs protein adsorption and interfacial activity.
Beaufils S; Grossmann JG; Renault A; Bolanos-Garcia VM
J Phys Chem B; 2008 Jul; 112(27):7984-91. PubMed ID: 18547097
[TBL] [Abstract][Full Text] [Related]
15. Protein phosphatase 5 in signal transduction.
Chinkers M
Trends Endocrinol Metab; 2001; 12(1):28-32. PubMed ID: 11137038
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of PP2A, but not PP5, mediates p53 activation by low levels of okadaic acid in rat liver epithelial cells.
Messner DJ; Romeo C; Boynton A; Rossie S
J Cell Biochem; 2006 Sep; 99(1):241-55. PubMed ID: 16598789
[TBL] [Abstract][Full Text] [Related]
17. Exploration of new drug-like inhibitors for serine/threonine protein phosphatase 5 of Plasmodium falciparum: a docking and simulation study.
Gupta S; Jadaun A; Kumar H; Raj U; Varadwaj PK; Rao AR
J Biomol Struct Dyn; 2015; 33(11):2421-41. PubMed ID: 25967133
[TBL] [Abstract][Full Text] [Related]
18. Protein phosphatase 5 promotes hepatocarcinogenesis through interaction with AMP-activated protein kinase.
Chen YL; Hung MH; Chu PY; Chao TI; Tsai MH; Chen LJ; Hsiao YJ; Shih CT; Hsieh FS; Chen KF
Biochem Pharmacol; 2017 Aug; 138():49-60. PubMed ID: 28528695
[TBL] [Abstract][Full Text] [Related]
19. Identification and biochemical characterization of protein phosphatase 5 from the cantharidin-producing blister beetle, Epicauta chinensis.
Chen X; Lü S; Zhang Y
Int J Mol Sci; 2013 Dec; 14(12):24501-13. PubMed ID: 24351830
[TBL] [Abstract][Full Text] [Related]
20. High yield expression of serine/threonine protein phosphatase type 5, and a fluorescent assay suitable for use in the detection of catalytic inhibitors.
Ni L; Swingle MS; Bourgeois AC; Honkanen RE
Assay Drug Dev Technol; 2007 Oct; 5(5):645-53. PubMed ID: 17939754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
